Valentech
Buenos Aires, Argentina· Est.
Valentech Pharma delivers innovative rare‑disease therapies across Latin America through a digital access and education platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Valentech Pharma delivers innovative rare‑disease therapies across Latin America through a digital access and education platform.
OncologyEndocrinologyMetabolismGastroenterologyHematologyNephrologyPulmonologyNeurology
Technology Platform
Valentech Access is a digital platform that streamlines compassionate‑use, early‑access, and expanded‑access drug programs, coupled with an online medical education portal (Valentech University) for healthcare professionals.
Opportunities
Expansion of rare‑disease therapeutic access across Latin America and leveraging the digital platform to partner with multinational pharma for early‑access programs.
Risk Factors
Regulatory heterogeneity across Latin American markets and reliance on external manufacturers for drug supply.
Competitive Landscape
Competes with regional rare‑disease distributors and global access‑program providers; differentiation lies in its integrated education and patient‑support services.